Thijs Spoor is confident that the new compounds his company is developing will soon allow PET scanners to do for cardiologists what they’ve done for cancer specialists. {read more here}

NEW YORK (Reuters Health) Dec 13 – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease and who are therefore deemed incurable, according to a UK team. {read more here}

F-18 labeled fluorodihydroxyphenylalanine (F-18 FDOPA) appears to find more cancer for patients with neuroendocrine tumors who have had negative conventional and somatostatin receptor scintigraphy, according to a study published Dec. 16 in the Journal of Nuclear Medicine. {read more here}

PET/MR hybrid scanners represent a leap forward for cardiac imaging, but technical challenges and reimbursement hurdles still limit widespread clinical use, according to a presentation at the annual meeting of the Radiological Society of North America (RSNA). {read more here}